Amplia Therapeutics (ASX:ATX) Other Long Term Assets : A$0.05 Mil (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Amplia Therapeutics Other Long Term Assets?

Amplia Therapeutics's other long-term assets for the quarter that ended in Sep. 2024 was A$0.05 Mil.

Amplia Therapeutics's quarterly other long-term assets increased from Sep. 2023 (A$0.05 Mil) to Mar. 2024 (A$0.05 Mil) but then stayed the same from Mar. 2024 (A$0.05 Mil) to Sep. 2024 (A$0.05 Mil).

Amplia Therapeutics's annual other long-term assets increased from Mar. 2022 (A$0.00 Mil) to Mar. 2023 (A$0.05 Mil) and increased from Mar. 2023 (A$0.05 Mil) to Mar. 2024 (A$0.05 Mil).

Amplia Therapeutics Other Long Term Assets Historical Data

The historical data trend for Amplia Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplia Therapeutics Other Long Term Assets Chart

Amplia Therapeutics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Long Term Assets

Get a 7-Day Free Trial

0.05

Amplia Therapeutics Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Other Long Term Assets	Get a 7-Day Free Trial															0.05	0.05	0.05	0.05	0.05

Amplia Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Amplia Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amplia Therapeutics Ltd (ASX:ATX) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

INNMF:USA

Address

350 Queen Street, Level 17, Melbourne, VIC, AUS, 3000

Website

https://www.ampliatx.com

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Amplia Therapeutics Headlines

No Headlines